摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2,5-dimethoxy-3,4,6-trimethylphenyl)methanol | 117574-74-0

中文名称
——
中文别名
——
英文名称
(2,5-dimethoxy-3,4,6-trimethylphenyl)methanol
英文别名
2,5-dimethoxy-3,4,6-trimethyl-benzyl alcohol;3.6-Dimethoxy-2.4.5-trimethyl-1-hydroxymethyl-benzol;2,5-Dimethoxy-3,4,6-trimethyl-benzylalkohol;2,5-dimethoxy-3,4,6-trimethylbenzylalcohol
(2,5-dimethoxy-3,4,6-trimethylphenyl)methanol化学式
CAS
117574-74-0
化学式
C12H18O3
mdl
——
分子量
210.273
InChiKey
XQCGKSRFUNJKJW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    120-121 °C
  • 沸点:
    333.8±37.0 °C(Predicted)
  • 密度:
    1.050±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    15
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    38.7
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Certain benzoquinones, naphthoquinones, corresponding hydroquinones
    申请人:Takeda Chemical Industries, Ltd.
    公开号:US04851413A1
    公开(公告)日:1989-07-25
    Quinone derivatives represented by the general formula ##STR1## (wherein, R.sup.1 and R.sup.2, the same or different, refer to a hydrogen atom, methyl or methoxymethyl group, or R.sup.1 and R.sup.2 bind together to form --CH.dbd.CH--CH.dbd.CH--; R.sup.3 is a hydrogen atom or methyl group; R.sup.4 is a nitrogen-containing heterocyclic group which may be substituted; R.sup.5 is a hydrogen atom, methyl group, hydroxymethyl group which may be substituted, or a carboxyl group which may be esterified or amidated; Z is ##STR2## (wherein, R' is hydrogen atom or methyl group); n is an integer from 0 through 12, m is an integer from 0 through 3, and k is an integer from 0 through 7, providing that, when m is 2 or 3, Z and k are able to vary appropriately in the repeating unit shown in [ ]), and the hydroquinone derivatives thereof, are novel compounds, possess improvement effects of metabolism of polyunsaturated fatty acids, particularly two or more of inhibition of production of fatty acid peroxides, inhibition of production of metabolites in 5-lipoxygenase pathway, inhibition of thromboxane A.sub.2 synthetase, thromboxane A.sub.2 receptor antagonism and scavenging action of active oxygen species, and of use as drugs, such as antithrombotics, anti-vascular constriction agents, anti-asthma agent, antiallergic agents, therapeutics for psoriasis, agents for improvement in heart, brain and cardiovascular systems, therapeutics for nephritis, active oxygen-eliminating agents, anticancer agents, agents for improvement of control of arachidonate cascade products, etc.
    喹醌衍生物由通式表示##STR1##(其中,R.sup.1和R.sup.2,相同或不同,指氢原子,甲基或甲氧基甲基基团,或R.sup.1和R.sup.2结合在一起形成--CH.dbd.CH--CH.dbd.CH--; R.sup.3是氢原子或甲基; R.sup.4是氮含杂环基团,可能被取代; R.sup.5是氢原子,甲基,可能被取代的羟甲基基团,或者酯化或酰胺化的羧基; Z是##STR2##(其中,R'是氢原子或甲基); n是0到12之间的整数,m是0到3之间的整数,k是0到7之间的整数,假设当m为2或3时,Z和k能够适当变化在[ ]中显示的重复单元中),以及其对氢醌衍生物,是新颖的化合物,具有改善多不饱和脂肪酸代谢的效果,特别是抑制脂肪酸过氧化物的产生,抑制5-脂氧合酶途径代谢产物的产生,抑制血栓素A.sub.2合成酶,血栓素A.sub.2受体拮抗作用和活性氧物质的清除作用,以及作为药物的用途,如抗血栓药、抗血管收缩剂、抗哮喘药、抗过敏药、治疗银屑病、改善心脏、脑和心血管系统的药物、治疗肾炎、活性氧清除剂、抗癌药、改善阿拉基酸级联产物控制的药物等。
  • Certain benzoquinones, naphthoquinones and derivatives thereof which
    申请人:Takeda Chemical Industries, Ltd.
    公开号:US04985447A1
    公开(公告)日:1991-01-15
    Quinone derivatives represented by the general formula ##STR1## (wherein, R.sup.1 and R.sup.2, the same or different, refer to hydrogen atom, methyl or methoxymethyl group, or R.sup.1 and R.sup.2 bind together to form --CH.dbd.CH--CH.dbd.CH--; R.sup.3 is hydrogen atom or methyl group; R.sup.4 is nitrogen-containing heterocyclic group which may be substituted; R.sup.5 is hydrogen atom, methyl group, hydroxymethyl group which may be substituted, or carboxyl group which may be esterified or amidated; Z is ##STR2## --CH.dbd.CH--, ##STR3## or ##STR4## (wherein, R' is hydrogen atom or methyl group); n is an integer from 0 through 12, m is an integer from 0 through 3, and k is an integer from 0 through 7, providing that, when m is 2 or 3, Z and k are able to vary appropriately in the repeating unit shown in [ ]), and the hydroquinone derivatives thereof, are novel compounds, possess improvement effects of metabolism of poly unsaturated fatty acids, particularly two or more inhibitition of production of fatty acid peroxides, inhibition of production of metabolites in 5-lipoxygenase pathway, inhibition of thromboxane A.sub.2 synthetase, thromboxane A.sub.2 receptor antagonism and scavenging action of active oxygen species, and of use as drugs, such as antithrombotics, anti-vascular constriction agents, anti-asthma agent, antiallergic agents, therpeutics for psoriasis, agents for improvement in heart, brain and cardiovascular systems, therapeutics for nephritis, active oxygen-eliminating agents, anticancer agents, agents for improvement of control of arachidonate cascade products, etc.
    通式为##STR1##的醌衍生物(其中,R.sup.1和R.sup.2,相同或不同,指氢原子,甲基或甲氧甲基基团,或R.sup.1和R.sup.2结合形成--CH.dbd.CH--CH.dbd.CH--; R.sup.3是氢原子或甲基基团; R.sup.4是可能被取代的含氮杂环基团; R.sup.5是氢原子,甲基基团,可能被取代的羟甲基基团,或可酯化或酰胺化的羧基; Z是##STR2## --CH.dbd.CH--, ##STR3## 或 ##STR4##(其中,R'是氢原子或甲基基团); n是0到12的整数,m是0到3的整数,k是0到7的整数,但当m为2或3时,Z和k能够在[ ]中所示的重复单位中适当变化),以及其羟醌衍生物,是新颖的化合物,具有改善多不饱和脂肪酸代谢的效果,特别是抑制脂肪酸过氧化物的产生,抑制5-脂氧合酶途径代谢物的产生,抑制血栓素A.sub.2合酶,血栓素A.sub.2受体拮抗作用和活性氧自由基清除作用,并可用作药物,如抗血栓剂,抗血管收缩剂,抗哮喘剂,抗过敏剂,治疗银屑病的药物,改善心脏,脑和心血管系统的药物,治疗肾炎的药物,活性氧清除剂,抗癌剂,改善花生四烯酸级联产物控制的药物等。
  • Riering, Helmut; Schaefer, Hans J., Chemische Berichte, 1994, vol. 127, # 5, p. 859 - 874
    作者:Riering, Helmut、Schaefer, Hans J.
    DOI:——
    日期:——
  • Smith et al., Journal of Organic Chemistry, 1939, vol. 4, p. 340
    作者:Smith et al.
    DOI:——
    日期:——
  • Quinone derivatives, their production and use
    申请人:Takeda Chemical Industries, Ltd.
    公开号:EP0234729B1
    公开(公告)日:1991-12-27
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐